The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.

The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).

The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.

The Josep Carreras Leukaemia Research Institute (IJC) is looking for a Laboratory Technician to join the Epigenetic Control of Haematopoiesis Group, led by Dr. José Luis Sardina. Este contrato es parte de la actuación CNS2024-154797 financiado por MICIU/AEI/10.13039/ 501100011033.

RESEARCH DESCRIPTION

We combine CRISPR-based epigenome editing, artificial intelligence (AI), and innovative mouse models to explore the molecular drivers of blood cancers. Using CRISPR, we precisely manipulate DNA methylation at specific genomic loci, while AI helps us interpret high-dimensional datasets to predict outcomes, identify regulatory networks, and uncover hidden patterns. Our disease-relevant mouse models allow us to validate discoveries in vivo and assess the real-world impact of epigenetic alterations.

This integrative approach enables us to dissect the causal roles of DNA methylation, revealing insights into chromatin dynamics, enhancer activity, and transcriptional regulation. By decoding how aberrant transcriptional programs contribute to cancer initiation and progression, we aim to identify novel therapeutic targets and epigenetic biomarkers. Our ultimate goal is to transform patient care through precision medicine while advancing the frontiers of leukemia research.

MAIN RESPONSABILITIES

• Maintain laboratory organization and manage records, supplies, and inventory.
• Prepare and manage reagents, samples, and equipment for both routine tasks and specific projects.
• Oversee the transgenic mouse colony, including breeding and genotyping.
• Support experimental work across sub-projects as needed.
• Handle laboratory purchasing and liaise with suppliers to ensure timely procurement.

WHAT WE NEED

• A degree in Biology or a related field.
• Previous experience in a biomedical research laboratory
• Accreditation for animal experimentation.
• Willingness to learn and strong teamwork skills
• Organized, proactive, self-motivated, and enthusiastic.
• Fluent in English.

WHAT WE OFFER

• A full-time contract.
• A competitive salary adjusted according to the experience of the candidate.

• The opportunity to contribute to cutting-edge translational research projects in the stimulating environment of the Josep Carreras Leukaemia Research Institute.
• Work in a mixed basic and clinical research environment at the Josep Carreras Leukaemia Research Institute.
• The stimulating environment of the Barcelona metropolitan area.
• Opportunity for professional growth in an advanced research environment.

DEADLINE

Please submit your application by August 10th, 2025

WHO WE ARE?

What makes us different?

The mission of the Josep Carreras Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research multicampus that contributes to the improvement of results, and the cure of patients affected by leukemia and other malignant hemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.

HR Excellence

In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start-up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.

The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.